Computer-Aided Detection of Malignancy with Magnetic Resonance Imaging of the Breast
DESCRIPTION
Computer-aided detection (CAD) is proposed as a supplement to a radiologist’s interpretation of contrast-enhanced magnetic resonance imaging (MRI) of the breast. CAD is intended to improve the specificity of MRI in detecting or measuring malignant tissue.
POLICY
Computer-aided detection for interpretation of contrast-enhanced magnetic resonance imaging of the breast is considered investigational.
See also:
IMPORTANT REMINDER
We develop Medical Policies to provide guidance to Members and Providers. This Medical Policy relates only to the services or supplies described in it. The existence of a Medical Policy is not an authorization, certification, explanation of benefits or a contract for the service (or supply) that is referenced in the Medical Policy. For a determination of the benefits that a Member is entitled to receive under his or her health plan, the Member's health plan must be reviewed. If there is a conflict between the Medical Policy and a health plan, the express terms of the health plan will govern.
ADDITIONAL INFORMATION
Published well-designed, randomized, controlled trials and studies in peer review journals is lacking, therefore, the evidence is insufficient to determine whether the use of computer-aided detection with MRI of the breast improves net health outcomes.
SOURCES
Berman, C. G. (2007). Recent advances in breast-specific imaging. Cancer Control, 14 (4), 338-349.
BlueCross BlueShield Association. Medical Policy Reference Manual. (6:2010). Computer-aided evaluation of malignancy with magnetic resonance imaging of the breast (6.01.45). Retrieved January 6, 2011 from BlueWeb. (10 articles and/or guidelines reviewed)
ECRI Institute. Health Technology Information Service. Emerging Technology (TARGET) Evidence Report. (2007, October). Computer-assisted detection (CAD) with magnetic resonance imaging (MRI) to detect breast cancer. Retrieved June 25, 2009 from ECRI Institute. (8 articles and/or guidelines reviewed)
Ellis, R. L., Meade, A. A., Mathiason, M. A., Willison, K. M., & Logan-Young, W. (2007). Evaluation of computer-aided detection systems in the detection of small invasive breast carcinoma. Radiology, 245 (1), 88-94. (Level 4 Evidence - Independent study)
Lehman, C. D., Peacock, S., DeMartini, W. B., & Chen, X. (2006). A new automated software system to evaluate breast MR examinations: Improved specificity without decreased sensitivity. American Journal of Roentgenology, 187 (1), 51-56. (Level 4 Evidence - Independent study)
Khoo, L. A., Taylor, P., & Given-Wilson, R. M. Computer-aided detection in the United Kingdom National Breast Screening Programme: Prospective study. Radiology, 237 (2), 444-449. (Level 3 Evidence - Independent study)
Technology Evaluation Center. (2006, June). Computer-aided detection of malignancy with magnetic resonance imaging of the breast. (Vol. 21, No.4). Chicago: BlueCross BlueShield Association. (38 articles and/or guidelines reviewed)
U. S. Food and Drug Administration. (2004, July). Center for Devices and Radiological Health. 510(k) Premarket Notification Database. K041286. Retrieved June 25, 2009 from http://www.accessdata.fda.gov/cdrh_docs/pdf4/k041286.pdf.
U. S. Food and Drug Administration. (2003, June). Center for Devices and Radiological Health. 510(k) Premarket Notificatin Database. K031350. Retrieved June 25, 2009 from http://www.accessdata.fda.gov/cdrh_docs/pdf3/K031350.pdf.
ORIGINAL EFFECTIVE DATE: 10/13/2007
MOST RECENT REVIEW DATE: 3/10/2011
ID_BA
Policies included in the Medical Policy Manual are not intended to certify coverage availability. They are medical determinations about a particular technology, service, drug, etc. While a policy or technology may be medically necessary, it could be excluded in a member's benefit plan. Please check with the appropriate claims department to determine if the service in question is a covered service under a particular benefit plan. Use of the Medical Policy Manual is not intended to replace independent medical judgment for treatment of individuals. The content on this Web site is not intended to be a substitute for professional medical advice in any way. Always seek the advice of your physician or other qualified health care provider if you have questions regarding a medical condition or treatment.
This document has been classified as public information.